VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,517,889 | -4.4% | 93,568 | +7.0% | 0.26% | -1.5% |
| Q2 2023 | $2,634,184 | +2.8% | 87,486 | -72.4% | 0.27% | +87.4% |
| Q1 2023 | $2,563,025 | -4.4% | 316,817 | +238.7% | 0.14% | +19.2% |
| Q4 2022 | $2,680,639 | +37.3% | 93,532 | +15.5% | 0.12% | +4.3% |
| Q3 2022 | $1,952,000 | -6.2% | 80,948 | +9.5% | 0.12% | -37.8% |
| Q2 2022 | $2,082,000 | -31.9% | 73,927 | -7.2% | 0.18% | +7.6% |
| Q1 2022 | $3,057,000 | +37.5% | 79,701 | +14.8% | 0.17% | -8.5% |
| Q4 2021 | $2,223,000 | +18.4% | 69,411 | +20.2% | 0.19% | +25.3% |
| Q1 2021 | $1,877,000 | +76.1% | 57,739 | +95.0% | 0.15% | +53.1% |
| Q4 2020 | $1,066,000 | – | 29,608 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |